Susquehanna International Group
CYAD

Susquehanna International Group’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Susquehanna International Group’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,602
Closed -$16K – 14248
2022
Q3 		$16K Buy
+11,602
New +$21.4K ﹤0.01% 12688

Other funds holding CYAD

FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's CYAD Position: Q4 2022 in Review

Susquehanna International Group sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q4 2022, closing a stake of 11,602 shares — an estimated $16K sold.

Susquehanna International Group first reported a position in CYAD in Q3 2022 and held it in 1 quarter. The position peaked at $16K in Q3 2022. 8 funds tracked by Wall St. Rank hold CYAD as of Q4 2022.

  • Susquehanna International Group reported no remaining Celyad Oncology SA American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 11,602 Celyad Oncology SA American Depositary Shares shares in Q4 2022, an estimated $16K.
  • Susquehanna International Group first reported a position in Celyad Oncology SA American Depositary Shares in Q3 2022 and held it in 1 quarter.
  • Susquehanna International Group's Celyad Oncology SA American Depositary Shares position peaked at $16K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.